Articles
Papers and Presentations
- Stock Nod
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- Sun Herald
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- TV Newscheck
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received
- The Daily-Record.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- The-Review.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- WBBM 780
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received
- WCCO.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- WaferNews
ElectroIQ - ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
- Washington G2 Reports - ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company
- Worth
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received
- Times-Gazette.com
ReVision Optics, Inc. Secures $35 Million in Capital Funding as US Clinical Trials Begin
An ophthalmic surgical products company, recently received $35 million in capital funding
Pages:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
|
